Navigation Links
MEDIAN Technologies Lesion Management Solutions Set the Trend in Diagnostic Oncology Imaging at RSNA 2007
Date:11/20/2007

SOPHIA ANTIPOLIS, France, November 20 /PRNewswire/ -- With the recent FDA approval of LMS-Lung/Track and LMS-Liver, two applications dedicated to the evaluation and follow-up of cancerous or other potentially malignant lesions identified in chest and liver CT images, MEDIAN Technologies succeeds in setting the trend in diagnostic oncology imaging. The company will showcase its complete portfolio of Lesion Management Solutions at the 93rd annual meeting of the Radiological Society of North America (RSNA) in Chicago, hall B, booth #8548.

LMS-Lung/Track and LMS-Liver are designed to efficiently assist the radiologists in all steps from lesion measurement and follow-up to report generation for the referring physicians. The applications segment user-identified lesions and measure their key characteristics such as volume and longest axial diameters. They also pair the lesions in follow-up exams, compute their growth and doubling time and finally generate reports according to the RECIST criteria used in oncology to assess the response to treatment of solid tumors. LMS-Lung/Track and LMS-Liver thus perform automatically all the tedious tasks the radiologists would normally carry out manually. This contributes to improving the workflow and reducing intra and inter-observer variability.

"Diagnostic oncology imaging is all about evaluating and following cancerous and suspicious lesions, such as pulmonary nodules," explained Fredrik Brag, CEO of MEDIAN Technologies. "MEDIAN Technologies is a specialized company focusing on delivering high-end solutions for all radiologists to accurately perform such evaluation and transmit the oncologists and other referring physicians the exact information they need in a record time. In brief, we can say that we work for the clinicians, so that they can provide the best possible patient care."

LMS-Lung/Track and LMS-Liver support images acquired on any multi-slice CT scanner, and can be integrated with modality or PACS/RIS workstations. "Integrating advanced clinical applications with PACS or RIS workstations is key in diagnostic oncology imaging. It guarantees access to the patients' previous exams necessary to perform follow-up studies and allows an immediate report transmission to the oncologists," said Gerard Milhiet, COO of MEDIAN Technologies. "We are proud to contribute to this breakthrough by bringing our applications right to the clinicians' desktops instead of having them move to dedicated workstations."

MEDIAN Technologies is currently deploying its LMS applications in 15 countries across Europe and expects to do the same in the US in the coming months, with the recent extension of its American sales force.

About MEDIAN Technologies

MEDIAN Technologies develops and sells advanced clinical applications for diagnostic oncology imaging. The company's product line, MEDIAN LMS - Lesion Management Solutions - is a comprehensive portfolio of clinical applications for the management of cancerous or other potentially malignant lesions diagnosed in chest and abdominal CT scans. LMS applications feature LMS-Liver, LMS-Lung/Track, LMS-Lung(*) and LMS-Colon*.

For further information please check MEDIAN Technologies website: http://www.mediantechnologies.com.

---------------------------------

(*) Not FDA approved

Contact: Raphaelle Imbernon

Company: MEDIAN Technologies

Address: 120 rue Albert Caquot, 06410 Biot, France

Phone: +33-492-906-589

Fax: +33-492-906-599

Email: raphaelle.imbernon@mediantechnologies.com

URL: http://www.mediantechnologies.com


'/>"/>
SOURCE MEDIAN Technologies
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Beleza ... Army body fat composition regulations. This is the first time that Coolsculpting is ... screened at least every six months to ensure they meet the prescribed body-fat standard, ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... in scholarships to students studying complementary medicine. Allison Outerbridge is this year’s ... her award on May 18 at the university’s Student Leadership Awards ceremony. , ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research ... their dogs straight off the grill. Of the 90 percent of Americans who say ... a hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... On Memorial ... and women who lost their lives in military battle for the country. The ... in 2015 to provide more programs that empower independence for disabled military veterans, as ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016  Granger Diagnostics today announced immediate ... wounds and infections. This test ensures discovery of ... viruses. The test requires only a simple swab of ... David G. Bostwick , MD, Chief Medical ... wound healing: "We are excited to make available, ...
(Date:5/25/2016)... 25, 2016 ReportsnReports.com adds ... report that provides an overview on therapeutic pipeline ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Chronic ...
(Date:5/24/2016)... , May 24, 2016   ... endpoints demonstrating non-inferiority in overall bowel cleansing and superiority ... c leansing of the ... http://photos.prnewswire.com/prnh/20130829/633895-a ) , Norgine B.V. today announced new ... litre PEG and ascorbate bowel preparation) versus standard 2 litre PEG ...
Breaking Medicine Technology: